Generic and diabetes-specific well-being in the AT.LANTUS follow-on study : further psychometric validation of the W-BQ28 indicates its utility in research and clinical practice in type 2 diabetes in the UK


Autoria(s): Speight, J.; Khagram, L. A.; Davies, M. J.
Data(s)

01/09/2012

Resumo

<b>Aims  </b>To undertake further psychometric validation of the W-BQ28 to determine its suitability for use in adults with Type 2 diabetes in the UK using data from the AT.LANTUS follow-on study.<br /><br /><b>Methods</b>  A total of 353 people with Type 2 diabetes participated in the AT.LANTUS Follow-on study, completing measures of well-being (W-BQ28), treatment satisfaction (DTSQ) and self-care (SCI-R). Confirmatory factor analyses was used to confirm the W-BQ28 structure and internal consistency reliability was assessed. Additional statistical tests were conducted to explore convergent, divergent and known-groups validity. Minimal important differences were calculated using distribution and anchor-based techniques.<br /><br /><b>Results  </b>Structure of the W-BQ28 (seven four-item subscales plus 16-item generic and 12-item diabetes-specific scales) was confirmed (comparative fit index = 0.917, root mean square error of approximation (RMSEA) = 0.057). Internal consistency reliability was satisfactory (four-item subscales: alpha = 0.73–0.90; 12/16-item scales: α = 0.84–0.90). Convergent validity was supported by expected moderate to high correlations (rs = 0.35–0.67) between all W-BQ28 subscales (except Energy); divergent validity was supported by expected low to moderate correlations with treatment satisfaction (rs = −0.03–0.52) and self-care (rs = 0.02–0.22). Known-groups validity was supported with statistically significant differences by sex, age and HbA1c for expected subscales. Minimal important differences were established (range 0.14–2.90).<br /><br /><b>Conclusions  </b>The W-BQ28 is a valid and reliable measure of generic and diabetes-specific well-being in Type 2 diabetes in the UK. Confirmation of the utility of W-BQ28 (including establishment of minimal important differences) means that its use is indicated in research and clinical practice.<br />

Identificador

http://hdl.handle.net/10536/DRO/DU:30052418

Idioma(s)

eng

Publicador

Wiley - Blackwell Publishing

Relação

http://dro.deakin.edu.au/eserv/DU:30052418/speight-genericanddiabetes-2012.pdf

http://dx.doi.org/10.1111/j.1464-5491.2012.03702.x

Direitos

2012, Wiley-Blackwell Publishing

Palavras-Chave #AT.LANTUS trial #psychometric validation #type 2 diabetes #W-BQ28 #well-being
Tipo

Journal Article